Glaukos (GKOS) Gains 51.9% YTD: What's Driving the Stock?

With healthy fundamentals and strong growth opportunities, this Zacks Rank #3 (Hold) company appears to be a solid wealth creator for its investors at the moment. Glaukos (GKOS) witnessed strong momentum in the year-to-date period. Shares of the company surged 51.9% compared with 4.3% growth of the industry. The S&P 500 Composite has risen 14.3% during the same time frame. Image Source: Zacks Investment Research Headquartered in San Clemente, CA, Glaukos is an ophthalmic medical technology and pharmaceutica ...